Sukumar Nagendran - 06 Jun 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director
Signature: /s/ David Tyronne Howton as attorney-in-fact for Sukumar Nagendran
Issuer symbol: SLDB
Transactions as of: 06 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 08 Jun 2023, 21:19:49 UTC
Previous filing: 18 May 2023
Next filing: 18 Dec 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Director Stock Option (Right to Buy)	Award	$0	+9,650		$0.000000	9,650	06 Jun 2023	Common Stock	9,650	$6.37	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.